Literature DB >> 15225709

Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-disubstituted ureas.

Brent R Stranix1, Gilles Sauvé, Abderrahim Bouzide, Alexandre Coté, Guy Sévigny, Jocelyn Yelle, Valérie Perron.   

Abstract

A series of lysine sulfonamide analogues bearing a Nepsilon-benzylic ureas was synthesized using both solution-phase and solid-phase approaches. A novel synthetic route of Nalpha-(alkyl)-Nalpha-(sulfonamides)lysinol using alpha-amino-caprolactam was developed. Evaluation of these novel protease inhibitors revealed compounds with high potency against wild-type HIV virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225709     DOI: 10.1016/j.bmcl.2004.05.049

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV.

Authors:  Arun K Ghosh; Zachary L Dawson; Hiroaki Mitsuya
Journal:  Bioorg Med Chem       Date:  2007-09-14       Impact factor: 3.641

2.  In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1.

Authors:  Serge Dandache; Guy Sévigny; Jocelyn Yelle; Brent R Stranix; Neil Parkin; Jonathan M Schapiro; Mark A Wainberg; Jinzi J Wu
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.